FDA PMA FDA Class 3 Approved 🇺🇸 United States

Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer

PMA: P000021 · Supplement: S020 · Decision Nov 23, 2011
Classifications
1
FEI Numbers
15
Registration Numbers
15

Basic Information

Device Name
Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
Trade Name
DIMENSION VISTA TPSA FLEX REAGENT CARTRIDGE FOR USE ON THE DIMENSION VISTA 500 SYSTEM
PMA Number
P000021
Supplement Number
S020
Device Class
FDA Class 3
Product Code
MTF
Generic Name
Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer
Medical Specialty
Unknown
Advisory Committee
Immunology
Decision
Approved
Decision Code
APPR
Decision Date
November 23, 2011
Date Received
June 30, 2011
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

APPROVAL FOR THE DIMENSION VISTA TPSA FLEX REAGENT CARTRIDGE FOR USE ON THE DIMENSION VISTA 500 SYSTEM.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MTF Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer